ロード中...
HDAC Inhibition and Graft Versus Host Disease
Histone deacetylase (HDAC) inhibitors are currently used clinically as anticancer drugs. Recent data have demonstrated that some of these drugs have potent antiinflammatory or immunomodulatory effects at noncytotoxic doses. The immunomodulatory effects have shown potential for therapeutic benefit af...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
ScholarOne
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105142/ https://ncbi.nlm.nih.gov/pubmed/21298214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|